Are drug safety measures harmonized? A real-world data from three regulatory authorities

被引：0
|
作者：
Alelayan, Sadeem Fahad [1 ]
Al-Sheikh, Leena A.
Almutawa, Rana [2 ]
Alkofide, Hadeel [1 ]
Alshammari, Thamir M. [3 ]
机构：
[1] King Saud Univ, Coll Pharm, Dept Clin Pharm, Riyadh, Saudi Arabia
[2] King Saud Univ, Coll Pharm, Riyadh, Saudi Arabia
[3] Saudi Food & Drug Author, Riyadh, Saudi Arabia
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2022年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
1287
引用
收藏
页码：599 / 600
页数：2
相关论文
共 50 条
  • [21] The use of real-world data in drug repurposing
    Park, Kyungsoo
    TRANSLATIONAL AND CLINICAL PHARMACOLOGY, 2021, 29 (03) : 117 - 124
  • [22] Using real-world data for supporting regulatory decision making: Comparison of cardiovascular and safety outcomes of an empagliflozin randomized clinical trial versus real-world data
    Jang, Ha Young
    Kim, In-Wha
    Oh, Jung Mi
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [23] The use of real-world data/evidence in regulatory submissions
    Song, Fuyu
    Zang, Chenxuan
    Ma, Xinyi
    Hu, Sifan
    Sun, Qiqing
    Chow, Shein-Chung
    Sun, Hongqiang
    CONTEMPORARY CLINICAL TRIALS, 2021, 109
  • [24] Comparison of two assessments of real-world data and real-world evidence for regulatory decision-making
    Yuan, Lily
    Rahman, Motiur
    Concato, John
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (01):
  • [25] Real-World Battles with Real-World Data
    Brown, Jeffrey
    Bate, Andrew
    Platt, Robert
    Raebel, Marsha
    Sauer, Brian
    Trifiro, Gianluca
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 254 - 255
  • [26] Using real-world safety data in regulatory approval decisions: Sotagliflozin and the risk of diabetic ketoacidosis
    Fralick, Michael
    Kesselheim, Aaron S.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 (10) : 1322 - 1324
  • [27] A real-world drug safety surveillance study of lenvatinib from the FAERS database
    Yang, Yipin
    Wang, Yafen
    Chen, Bangjie
    Liu, Yuchen
    Gu, Kangsheng
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [28] The Use of Real-world Data to Generate Real-world Evidence to Accelerate Neonatal Drug Development
    Jackson, Shawn S.
    Cravero, Joseph P.
    Sun, Lena
    Davis, Jonathan M.
    JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY, 2025, 37 (01) : 110 - 113
  • [29] Sequential Epidemiological Analyses of Real-World Data: A Tool for Prospective Drug Safety Surveillance from the Rofecoxib Example
    Abbasi, Saad Hanif
    Lund, Lars Christian
    Hallas, Jesper
    Pottegard, Anton
    DRUG SAFETY, 2025, : 489 - 502
  • [30] REAL-WORLD SAFETY DATA FOR TBO-FILGRASTIM
    Lang, N.
    Lammerich, A.
    Mueller, U.
    Bias, P.
    HAEMATOLOGICA, 2014, 99 : 493 - 493
12345